28
Oct
2025

Nanjing King-Friend Biochemical Pharmace

Exhibitor at CPHI Frankfurt 2025 stand 3.0F32, Finished Dosage Formulations
About Us

A leading High-end Pharmaceutical Injectables manufacturer from China with over 60 ANDAs approved in USA. Top 3 supplier of Heparin and Enoxaparin APIs across the globe. 
Top exporter from China to US of Injetables with over 250 Million USD revenue per year.
Two manufacturing sites for Injectables and one API manufacturing site accrediated with USFDA,  EMA, PMDA. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2022
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • (86-25) 86990701
  • 16 Xuefu Road,High&New Tech Development Zone, 21006, Nanjing, J.S., China
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.0F32, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • Heparin Sodium/ Enoxaparin Sodium

    Product Heparin Sodium/ Enoxaparin Sodium

    API and FDF both Approved in US, EU, China, Brazil US GMP, EU GMP, Japan GMP, China GMP, Brazil GMP, Mexico GMP available. World’s most stable supply, best quality, competitive price.